Is Aspira Womens Stock a Good Investment?

Aspira Womens Investment Advice

  AWH
To provide specific investment advice or recommendations on Aspira Womens Health stock, we recommend investors consider the following general factors when evaluating Aspira Womens Health. This will help you to make an informed decision on whether to include Aspira Womens in one of your diversified portfolios:
  • Examine Aspira Womens' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Aspira Womens' leadership team and their track record. Good management can help Aspira Womens navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Aspira Womens' business and its evolving consumer preferences.
  • Compare Aspira Womens' performance and market position to its competitors. Analyze how Aspira Womens is positioned in terms of product offerings, innovation, and market share.
  • Check if Aspira Womens pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Aspira Womens' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Aspira Womens Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Aspira Womens Health is a good investment.
 
Sell
 
Buy
Strong Sell
We provide trade advice to complement the prevailing expert consensus on Aspira Womens Health. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Aspira Womens is not overpriced, please confirm all Aspira Womens Health fundamentals, including its price to earning, cash per share, target price, as well as the relationship between the gross profit and book value per share . As Aspira Womens Health appears to be a penny stock we also recommend to validate its price to earning numbers.

Market Performance

Very WeakDetails

Volatility

DangerousDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Aspira Womens Stock

Researching Aspira Womens' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 31.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.15. Aspira Womens Health last dividend was issued on the 16th of December 2016. The entity had 1:15 split on the 12th of May 2023.
To determine if Aspira Womens is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aspira Womens' research are outlined below:
Aspira Womens Health generated a negative expected return over the last 90 days
Aspira Womens Health has some characteristics of a very speculative penny stock
Aspira Womens Health has high historical volatility and very poor performance
The company reported the last year's revenue of 9.15 M. Reported Net Loss for the year was (16.69 M) with profit before taxes, overhead, and interest of 4.32 M.
Aspira Womens Health has about 20.48 M in cash with (15.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Aspira Womens Health has a poor financial position based on the latest SEC disclosures
Roughly 31.0% of the company shares are held by company insiders
Latest headline from gurufocus.com: Aspira Womens Health Inc Q3 2024 Earnings Call Highlights Strategic Wins Amidst Market ...

Aspira Womens Quarterly Good Will

388.6 Million

Aspira Womens uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aspira Womens Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aspira Womens' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Aspira Womens' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Aspira Womens' investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2018-11-08
2018-09-30-0.03-0.04-0.0133 
2018-05-14
2018-03-31-0.04-0.05-0.0125 
2018-03-13
2017-12-31-0.04-0.05-0.0125 
2017-05-11
2017-03-31-0.04-0.05-0.0125 
2016-11-10
2016-09-30-0.06-0.07-0.0116 
2021-03-25
2020-12-31-0.04-0.058-0.01845 
2023-03-22
2022-12-31-0.06-0.040.0233 
2022-11-10
2022-09-30-0.06-0.08-0.0233 

Know Aspira Womens' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Aspira Womens is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspira Womens Health backward and forwards among themselves. Aspira Womens' institutional investor refers to the entity that pools money to purchase Aspira Womens' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
M&t Bank Corp2024-06-30
15 K
Two Sigma Securities, Llc2024-06-30
13.5 K
Squarepoint Ops Llc2024-06-30
12.3 K
Hrt Financial Llc2024-06-30
10.9 K
Tower Research Capital Llc2024-06-30
6.7 K
Morgan Stanley - Brokerage Accounts2024-06-30
4.8 K
Royal Bank Of Canada2024-06-30
2.3 K
Advisor Group Holdings, Inc.2024-06-30
2.3 K
Jpmorgan Chase & Co2024-06-30
2.1 K
Armistice Capital, Llc2024-09-30
1.3 M
Vanguard Group Inc2024-09-30
274.1 K
Note, although Aspira Womens' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aspira Womens' market capitalization trends

The company currently falls under 'Micro-Cap' category with a total capitalization of 13.5 M.

Market Cap

32.21 Million

Aspira Womens' profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(2.67)(2.53)
Return On Capital Employed(16.49)(15.67)
Return On Assets(2.67)(2.53)
Return On Equity 7.06  7.41 
The company has Net Profit Margin of (1.79) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (1.81) %, which entails that for every $100 of revenue, it lost $1.81.
Determining Aspira Womens' profitability involves analyzing its financial statements and using various financial metrics to determine if Aspira Womens is a good buy. For example, gross profit margin measures Aspira Womens' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Aspira Womens' profitability and make more informed investment decisions.

Evaluate Aspira Womens' management efficiency

Aspira Womens Health has Return on Asset of (1.8571) % which means that on every $100 spent on assets, it lost $1.8571. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (7.2345) %, meaning that it generated no profit with money invested by stockholders. Aspira Womens' management efficiency ratios could be used to measure how well Aspira Womens manages its routine affairs as well as how well it operates its assets and liabilities. The Aspira Womens' current Return On Equity is estimated to increase to 7.41, while Return On Tangible Assets are forecasted to increase to (2.53). As of now, Aspira Womens' Fixed Asset Turnover is increasing as compared to previous years. The Aspira Womens' current Asset Turnover is estimated to increase to 1.53, while Total Assets are projected to decrease to under 5.9 M.
Last ReportedProjected for Next Year
Book Value Per Share(0.26)(0.24)
Tangible Book Value Per Share(0.26)(0.24)
Enterprise Value Over EBITDA(2.30)(2.41)
Price Book Value Ratio(15.93)(15.13)
Enterprise Value Multiple(2.30)(2.41)
Price Fair Value(15.93)(15.13)
Enterprise Value34.1 M32.4 M
Effective management at Aspira Womens has been a driving force behind its market achievements. We assess the correlation between management practices and financial success to determine the stock's value.
Beta
1.438

Basic technical analysis of Aspira Stock

As of the 29th of November, Aspira Womens shows the Standard Deviation of 4.89, mean deviation of 3.02, and Risk Adjusted Performance of (0.03). Aspira Womens Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aspira Womens' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aspira Womens insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aspira Womens' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aspira Womens insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Aspira Womens' Outstanding Corporate Bonds

Aspira Womens issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aspira Womens Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aspira bonds can be classified according to their maturity, which is the date when Aspira Womens Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Aspira Womens' technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Aspira Womens' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Aspira Womens' intraday indicators

Aspira Womens intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aspira Womens stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Aspira Womens time-series forecasting models is one of many Aspira Womens' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aspira Womens' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Aspira Stock media impact

Far too much social signal, news, headlines, and media speculation about Aspira Womens that are available to investors today. That information is available publicly through Aspira media outlets and privately through word of mouth or via Aspira internal channels. However, regardless of the origin, that massive amount of Aspira data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aspira Womens news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aspira Womens relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aspira Womens' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aspira Womens alpha.

Aspira Womens Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aspira Womens can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Aspira Womens Corporate Management

Michelle SniderSenior OperationsProfile
Ryan MDChief OfficerProfile
Emily GrangerDirector MarketingProfile
Robert CPAChief OfficerProfile
Michael NewtonVP CommercialProfile
Marlene McLennanInterim OfficerProfile

Already Invested in Aspira Womens Health?

The danger of trading Aspira Womens Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aspira Womens is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aspira Womens. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aspira Womens Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.15)
Revenue Per Share
0.801
Quarterly Revenue Growth
(0.03)
Return On Assets
(1.86)
Return On Equity
(7.23)
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Aspira Womens' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.